Among breast cancer patients, differences were also found according to molecular subtypes: while negative/low TGIF expression correlates with shorter DFS and OS in ER-positive BC, it lacks any prognostic significance in TNBC, suggesting an interference of TGIF and ER signaling, which was already described in osteoblasts [25]. This evidence concerns the gene ESR1 and breast carcinoma.